Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, Higashiyama S.
Asakura M, et al. Among authors: ishikura f.
Nat Med. 2002 Jan;8(1):35-40. doi: 10.1038/nm0102-35.
Nat Med. 2002.
PMID: 11786904